Mount Sinai’s Leading Cardiologist Releases Report on the Future of Global Health to Presidential Administration
A committee co-chaired by Mount Sinai’s top cardiologist proposed 14 recommendations today to deliver a strong global health strategy and to allow the United States to maintain its role as a global health leader.
The Consensus Committee on Global Health and the Future of the United States was established by the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine to assess the current global health landscape and examine how U.S. global health resources can be used more effectively and responsively. Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, was the committee’s co-chair.
The report found that the United States has long been a leader in global health, yet resources are not unlimited, and the case for continued commitment must be made. An overview of the committee’s report is available here.
"Investing in global health can save the lives of millions of children and result in positive returns on investment," said Dr. Fuster. "On the one hand we have security threats, and on the other hand we have the opportunity for shared solutions to common problems."
“Chronic illnesses like heart disease and cancer also continue to be a worldwide problem,” Dr. Fuster added. "Cardiovascular disease is the number one killer with 18 million deaths." He noted that the global cost is expected to reach more than $1 trillion by 2030. "The cost is huge and we are not responding."
Dr. Fuster is a past president of both the American Heart Association and the World Heart Federation. He is a member of the National Academy of Medicine, where he served as Chair of the Committee on Preventing the Global Epidemic of Cardiovascular Disease, and was a member of the National Heart, Lung, and Blood Council.
Dr. Fuster is an author of about 1,000 research articles and has received honorary doctorate degrees from 33 distinguished universities throughout the world.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the "Honor Roll" of best hospitals in America, ranked No. 15 nationally in the 2016-2017 "Best Hospitals" issue of U.S. News & World Report. The Mount Sinai Hospital is also ranked as one of the nation's top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai's Kravis Children's Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."